Pediatric subcutaneous treprostinil site maintenance and pain control strategies from the Pediatric Pulmonary Hypertension Network (original) (raw)
Add-On Therapy with Subcutaneous Treprostinil for Refractory Pediatric Pulmonary Hypertension
David Celermajer
The Journal of Pediatrics, 2011
View PDFchevron_right
Safety, efficacy and Management of subcutaneous treprostinil infusions in the treatment of severe pediatric pulmonary hypertension
Maria del Cerro
International Journal of Cardiology
View PDFchevron_right
Effectiveness and Safety of Inhaled Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Children
Usha Krishnan
The American Journal of Cardiology, 2012
View PDFchevron_right
Transition from parenteral to oral treprostinil in pulmonary arterial hypertension
Jeremy Feldman
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2016
View PDFchevron_right
Acute Pulmonary Vasodilator Testing With Inhaled Treprostinil in Children With Pulmonary Arterial Hypertension
Donna Parker
Pediatric Cardiology, 2013
View PDFchevron_right
Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
George Sokos, Amresh Raina
Pulmonary Circulation, 2013
View PDFchevron_right
An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil
Marcin Kurzyna
BMC pulmonary medicine, 2017
View PDFchevron_right
Efficacy of Long-term Subcutaneous Treprostinil Sodium Therapy in Pulmonary Hypertension
Meinhard Kneussl
Chest, 2006
View PDFchevron_right
Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension
Regina Steringer-mascherbauer
Clinical Research in Cardiology, 2017
View PDFchevron_right
Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation
Jeremy Feldman
Pulmonary Circulation, 2017
View PDFchevron_right
Safety and efficacy of transition from inhaled treprostinil to parenteral treprostinil in selected patients with pulmonary arterial hypertension
Ioana Preston, Nicholas Hill, Jeremy Feldman, Charles D Burger
Pulmonary circulation, 2014
View PDFchevron_right
Capsaicin 8% patch for treprostinil subcutaneous infusion site pain in pulmonary hypertension patients
Wendy Gin-Sing
British Journal of Anaesthesia, 2014
View PDFchevron_right
Inhaled treprostinil sodium for pulmonary hypertension
Richard A Krasuski
View PDFchevron_right
Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension
Johannes Jakowitsch
The Journal of Heart and Lung Transplantation, 2012
View PDFchevron_right
Treprostinil in the treatment of pulmonary arterial hypertension
Jade Fann
Future Cardiology, 2020
View PDFchevron_right
Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Controlled Trial
Keyur Parikh
Circulation, 2013
View PDFchevron_right
Transition protocol from subcutaneous treprostinil to intravenous epoprostenol in deteriorating patients with pulmonary arterial hypertension
Sophia-anastasia Mouratoglou
International Journal of Cardiology, 2020
View PDFchevron_right
Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension
harald gabriel
Heart (British Cardiac Society), 2018
View PDFchevron_right
Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease
Raymond Planinsic
Transplant International, 2009
View PDFchevron_right
Current and Emerging Therapies in Pulmonary Arterial Hypertension: Focus on Treprostinil
Melvyn Rubenfire
Clinical Medicine Reviews in Vascular Health, 2011
View PDFchevron_right
Tolerability and clinical efficacy of inhaled treprostinil in patients with group 1 pulmonary arterial hypertension
Charles D Burger
Therapeutic Advances in Chronic Disease, 2018
View PDFchevron_right
Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension
Simon Classen
The Journal of Heart and Lung Transplantation, 2018
View PDFchevron_right
Treprostinil Administered to Treat Pulmonary Artery Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial
Jeremy Feldman
Chest, 2016
View PDFchevron_right
Long-term therapy with oral treprostinil in pulmonary arterial hypertension failed to lead to improvement in important physiologic measures: results from a single center
Sonja Bartolome
Pulmonary Circulation, 2015
View PDFchevron_right
Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension
Frank Reichenberger
Pulmonary pharmacology & therapeutics, 2009
View PDFchevron_right
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension
Werner Seeger
The Journal of Heart and Lung Transplantation, 2011
View PDFchevron_right
Safety of epoprostenol and treprostinil in children less than 12 months of age
Brian Hanna, Natalie Rintoul
Pulmonary Circulation, 2013
View PDFchevron_right
sj-pdf-1-pul-10.1177_2045894019866335 - Supplemental material for Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics
Roblee Allen
2020
View PDFchevron_right
Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics
Jeremy Feldman
Pulmonary Circulation, 2020
View PDFchevron_right
An Observational Study of Inhaled‐Treprostinil Respiratory‐Related Safety in Patients with Pulmonary Arterial Hypertension
Charles D Burger
Pulmonary Circulation, 2016
View PDFchevron_right
Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial
Keyur Parikh
The Journal of Heart and Lung Transplantation, 2010
View PDFchevron_right
Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertension
Simon Classen
Pulmonary Circulation
View PDFchevron_right
Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension
Keyur Parikh
Circulation, 2013
View PDFchevron_right
Treprostinil-Based Therapy in the Treatment of Moderate-to-Severe Pulmonary Arterial Hypertension
ALI RAZA
Yearbook of Pulmonary Disease, 2009
View PDFchevron_right
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial
Ricardo De Amorim Corrêa
American Journal of Respiratory and Critical Care Medicine, 2019
View PDFchevron_right